Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy

Download

Shim MK, Park J, Yoon HY, Lee S, Um W, Kim JH, Kang SW, Seo JW, Hyun SW, Park JH, Byun Y, Kwon IC, Kim K.

J Control Release, 2019

Summary:

Follow researchers as they use Maestro technology to explore cancer nanomedicine techniques involving nanoparticle-based delivery systems, and attempt to solve the unavoidable problems that current nanomedicine practices face.

 

Related Resources
Enhanced drug internalization and therapeutic efficacy of PEGylated nanoparticles by one-step formulation with anti-mPEG bispecific antibody in intrinsic drug-resistant breast cancer
In vitro screening of silver nanoparticles and ionic silver using neural networks yields differential effects on spontaneous activity and pharmacological responses
In vitro screening of metal oxide nanoparticles for effects on neural function using cortical networks on microelectrode arrays
Targeting glioblastoma: Assessing the potency of T cells to kill cancer

Related Products

System

Maestro Pro

High-throughput MEA and live-cell analysis system

Learn more >>
Axion BioSystems Maestro Pro MEA system
System

Maestro Edge

MEA and live-cell analysis system

Learn more >>
Axion BioSystems Maestro Edge system for MEA assays
Software

Cardiac Module

Record the four key measures of cardiac performance: action potential, field potential, propagation, and contractility

Learn more >>
Axion BioSystems Cardiac software Module for MEA experiments